Identification of approved drugs with ALDH1A1 inhibitory potential aimed at enhancing chemotherapy sensitivity in cancer cells: an in-silico drug repurposing approach-Reference-Cited by-同舟云学术

Identification of approved drugs with ALDH1A1 inhibitory potential aimed at enhancing chemotherapy sensitivity in cancer cells: an in-silico drug repurposing approach

Published:2024-01-08 Issue: Volume: Page:1-15
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Paul Sanjay Kumar¹²^ORCID,Guendouzi Abdelmadjid³⁴,Banerjee Agniswar¹,Guendouzi Abdelkrim⁵,Haldar Rajen¹^ORCID

Affiliation:

1. Department of Physiology, University of Calcutta, Kolkata, India

2. Department of Zoology, Rammohan College, Kolkata, West Bengal, India

3. Center for Research in Pharmaceutical Sciences (CRSP), Constantine, Algeria

4. Ecole Normale Supérieure ENS Constantine, Constantine, Algeria

5. Department of Chemistry, University of Saida, Saida, Algeria

Funder

Indian Council of Medical Research

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2300127

Reference67 articles.

1. The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

2. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

3. Construction of the free energy landscape of biomolecules via dihedral angle principal component analysis

4. Unified understanding of folding and binding mechanisms of globular and intrinsically disordered proteins

5. The Protein Data Bank

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Ajuga Iva Extracts as Potential Candidates for Antidysmenorrhea Targeting Human COX2 and PGE2S‐1 through In Vitro and In Silico Drug Repurposing Approach;ChemistrySelect;2024-06-03

2. Applications of Molecular Docking Studies in SARS-CoV-2 Targeted Drug Discovery and the Gains Achieved through Molecular Docking;Unravelling Molecular Docking - From Theory to Practice [Working Title];2024-04-29